Showing results (391-400 of 1,062) with videos related to

Sort By:
Pageof 107
Alzheimer'S & Dementia (New York, N. Y.)|February 1, 2021
The association of circulating amylin with β-amyloid in familial Alzheimer's diseaseHan Ly, Nirmal Verma, Savita Sharma, et al.
Alzheimer'S & Dementia (New York, N. Y.)|February 3, 2021
CCCDTD5: Clinical role of neuroimaging and liquid biomarkers in patients with cognitive impairmentMélanie Brisson, Catherine Brodeur, Laurent Létourneau-Guillon, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 10, 2022
Prescribing cholinesterase inhibitors in mild cognitive impairment-Observations from the Alzheimer's Disease Neuroimaging InitiativeEddie Stage, Diana Svaldi, Sophie Sokolow, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 10, 2022
Effects of smartphone application-based cognitive training at home on cognition in community-dwelling non-demented elderly individuals: A randomized controlled trialHyemin Jang, Minyoung Yeo, Jinju Cho, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 10, 2022
Investigating cognition in midlifeJan S Novotný, Juan P Gonzalez-Rivas, Jose R Medina-Inojosa, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 10, 2022
Estimation of dementia prevalence at the local level in the United StatesErin E Bennett, Abraham Kwan, Kan Z Gianattasio, et al.
Alzheimer'S & Dementia (New York, N. Y.)|December 6, 2021
A ketogenic supplement improves white matter energy supply and processing speed in mild cognitive impairmentMaggie Roy, Mélanie Fortier, François Rheault, et al.
Alzheimer'S & Dementia (New York, N. Y.)|December 22, 2021
Dementia risk reduction: why haven't the pharmacological risk reduction trials worked? An in-depth exploration of seven established risk factorsRuth Peters, John Breitner, Sarah James, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 2, 2022
Identification of dementia and MCI cases in health information systems: An Italian validation studyIlaria Bacigalupo, Flavia L Lombardo, Anna Maria Bargagli, et al.
Alzheimer'S & Dementia (New York, N. Y.)|September 30, 2022
Sleep duration and biomarkers of inflammation in African American and white participants with a parental history of Alzheimer's diseaseVictoria M Pak, Sudeshna Paul, Dominika Swieboda, et al.
Pageof 107